Lifeworks Advisors’s Clorox CLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.95M Buy
72,797
+11,582
+19% +$1.11M 0.73% 47
2026
Q1
$6.34M Buy
61,215
+7,485
+14% +$849K 0.81% 37
2025
Q4
$5.42M Buy
53,730
+7,664
+17% +$832K 0.7% 45
2025
Q3
$5.68M Buy
46,066
+2,075
+5% +$258K 0.76% 38
2025
Q2
$5.28M Buy
43,991
+40,519
+1,167% +$5.41M 0.79% 36
2025
Q1
$511K Buy
+3,472
New +$530K 0.09% 177
2023
Q3
Sell
-1,438
Closed -$229K 183
2023
Q2
$229K Buy
1,438
+13
+0.9% +$2.1K 0.1% 146
2023
Q1
$225K Buy
+1,425
New +$214K 0.11% 136
2022
Q4
Sell
-1,755
Closed -$256K 117
2022
Q3
$256K Sell
1,755
-452
-20% -$65.2K 0.15% 111
2022
Q2
$311K Buy
+2,207
New +$315K 0.2% 100
2022
Q1
Sell
-8,391
Closed -$1.46M 129
2021
Q4
$1.46M Buy
+8,391
New +$1.4M 1.17% 26

Other funds holding CLX

Lifeworks Advisors's CLX Position: Q2 2026 in Review

Lifeworks Advisors increased its Clorox (CLX) stake by 19% in Q2 2026, buying an estimated $1.11M and bringing the position to 72,797 shares worth $6.95M. The position accounts for 0.73% of the portfolio, ranked #47.

Lifeworks Advisors first reported a position in CLX in Q4 2021 and has held it in 11 quarters since. 1,039 funds tracked by Wall St. Rank hold CLX as of Q2 2026.

  • Lifeworks Advisors held 72,797 shares of Clorox worth $6.95M as of Q2 2026.
  • Lifeworks Advisors bought 11,582 Clorox shares in Q2 2026, an estimated $1.11M.
  • Clorox made up 0.73% of Lifeworks Advisors's portfolio in Q2 2026, its #47 holding.
  • Lifeworks Advisors first reported a position in Clorox in Q4 2021 and has held it in 11 quarters since.
  • 1,039 funds tracked by Wall St. Rank held Clorox as of Q2 2026.

Based on Lifeworks Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.